Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416771837> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2416771837 endingPage "A449" @default.
- W2416771837 startingPage "A449" @default.
- W2416771837 abstract "Gastrointestinal stromal tumors (GIST) are rare but costly tumors with an estimated incidence of 1.5/100 000/year in Europe. Granting reimbursement requires locally adapted cost effectiveness data in Turkey. This study was conducted to estimate the costs-of disease and direct cost components of metastatic/inoperable GISTs that did not respond to prior imatinib mesylate and sunitinib malate. Bayer Turkey Market Access team organized an “expert panel” composed of oncologists to discuss the local treatments, routine monitoring and adverse event management algorithms in metastatic/inoperable GIST patients. The panel reviewed the global and local literature and guidelines and also discussed the spectrum of frequently performed local clinical practices. All cost components, including medications, hospitalization, out-patient follow-up procedures and rehabilitation services were reviewed. End of 2014 local prices for medications and procedures were used as sources. Based on the answers of the physicians, the cost of healthcare resources regarding the conditions described were calculated from the perspective of the Turkish payer (SSI – Social Security Institution). In metastatic/inoperable GIST patients, treatment should be continued indefinitely, since treatment interruption is generally followed by relatively rapid tumor progression in almost all cases, even when lesions have been previously surgically excised. The cost of routine monitoring in the follow-up of metastatic/inoperable GIST patients was estimated to be 62.40 TL/month during progression-free and post-progression periods, while it was 490.00 TL/month during the terminal phase. The greatest cost is estimated for hospitalization in the intensive care unit ranging from 200.00 to 800.55 TL per incident. The most common adverse reactions were listed as hand and foot skin reaction (4%) and diarrhea (6.7%). The costs of the disease, which therefore are quite high, estimated here will provide the most reliable data reflecting current figures to Public Stakeholders. Despite these high expenditures, those treatments’ efficacy is not clinically proven." @default.
- W2416771837 created "2016-06-24" @default.
- W2416771837 creator A5009634924 @default.
- W2416771837 creator A5011015769 @default.
- W2416771837 creator A5022702113 @default.
- W2416771837 creator A5023261313 @default.
- W2416771837 creator A5035526467 @default.
- W2416771837 creator A5065718437 @default.
- W2416771837 creator A5066530028 @default.
- W2416771837 creator A5081947778 @default.
- W2416771837 creator A5082338953 @default.
- W2416771837 creator A5084004150 @default.
- W2416771837 creator A5085637979 @default.
- W2416771837 creator A5060195475 @default.
- W2416771837 date "2015-11-01" @default.
- W2416771837 modified "2023-09-27" @default.
- W2416771837 title "The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey: an Expert Panel Approach for Estimation of Costs" @default.
- W2416771837 doi "https://doi.org/10.1016/j.jval.2015.09.1130" @default.
- W2416771837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26532527" @default.
- W2416771837 hasPublicationYear "2015" @default.
- W2416771837 type Work @default.
- W2416771837 sameAs 2416771837 @default.
- W2416771837 citedByCount "0" @default.
- W2416771837 crossrefType "journal-article" @default.
- W2416771837 hasAuthorship W2416771837A5009634924 @default.
- W2416771837 hasAuthorship W2416771837A5011015769 @default.
- W2416771837 hasAuthorship W2416771837A5022702113 @default.
- W2416771837 hasAuthorship W2416771837A5023261313 @default.
- W2416771837 hasAuthorship W2416771837A5035526467 @default.
- W2416771837 hasAuthorship W2416771837A5060195475 @default.
- W2416771837 hasAuthorship W2416771837A5065718437 @default.
- W2416771837 hasAuthorship W2416771837A5066530028 @default.
- W2416771837 hasAuthorship W2416771837A5081947778 @default.
- W2416771837 hasAuthorship W2416771837A5082338953 @default.
- W2416771837 hasAuthorship W2416771837A5084004150 @default.
- W2416771837 hasAuthorship W2416771837A5085637979 @default.
- W2416771837 hasBestOaLocation W24167718371 @default.
- W2416771837 hasConcept C121608353 @default.
- W2416771837 hasConcept C126322002 @default.
- W2416771837 hasConcept C141071460 @default.
- W2416771837 hasConcept C160735492 @default.
- W2416771837 hasConcept C162324750 @default.
- W2416771837 hasConcept C16930146 @default.
- W2416771837 hasConcept C177713679 @default.
- W2416771837 hasConcept C2775922572 @default.
- W2416771837 hasConcept C2777583451 @default.
- W2416771837 hasConcept C2778729363 @default.
- W2416771837 hasConcept C2779490328 @default.
- W2416771837 hasConcept C2779703844 @default.
- W2416771837 hasConcept C3019892230 @default.
- W2416771837 hasConcept C50522688 @default.
- W2416771837 hasConcept C71924100 @default.
- W2416771837 hasConceptScore W2416771837C121608353 @default.
- W2416771837 hasConceptScore W2416771837C126322002 @default.
- W2416771837 hasConceptScore W2416771837C141071460 @default.
- W2416771837 hasConceptScore W2416771837C160735492 @default.
- W2416771837 hasConceptScore W2416771837C162324750 @default.
- W2416771837 hasConceptScore W2416771837C16930146 @default.
- W2416771837 hasConceptScore W2416771837C177713679 @default.
- W2416771837 hasConceptScore W2416771837C2775922572 @default.
- W2416771837 hasConceptScore W2416771837C2777583451 @default.
- W2416771837 hasConceptScore W2416771837C2778729363 @default.
- W2416771837 hasConceptScore W2416771837C2779490328 @default.
- W2416771837 hasConceptScore W2416771837C2779703844 @default.
- W2416771837 hasConceptScore W2416771837C3019892230 @default.
- W2416771837 hasConceptScore W2416771837C50522688 @default.
- W2416771837 hasConceptScore W2416771837C71924100 @default.
- W2416771837 hasIssue "7" @default.
- W2416771837 hasLocation W24167718371 @default.
- W2416771837 hasOpenAccess W2416771837 @default.
- W2416771837 hasPrimaryLocation W24167718371 @default.
- W2416771837 hasRelatedWork W1559702962 @default.
- W2416771837 hasRelatedWork W1973125946 @default.
- W2416771837 hasRelatedWork W2006171747 @default.
- W2416771837 hasRelatedWork W2065325481 @default.
- W2416771837 hasRelatedWork W2081016143 @default.
- W2416771837 hasRelatedWork W2214800249 @default.
- W2416771837 hasRelatedWork W2238551114 @default.
- W2416771837 hasRelatedWork W2397935960 @default.
- W2416771837 hasRelatedWork W264746773 @default.
- W2416771837 hasRelatedWork W69309839 @default.
- W2416771837 hasVolume "18" @default.
- W2416771837 isParatext "false" @default.
- W2416771837 isRetracted "false" @default.
- W2416771837 magId "2416771837" @default.
- W2416771837 workType "article" @default.